Jaz inhibitors constitute a class of chemical compounds designed to target and interfere with the activity of proteins or molecules associated with the JAZ family. JAZ stands for Jasmonate-ZIM domain proteins, which are essential components in plant signaling pathways. These inhibitors are developed with the aim of modulating the function of JAZ proteins or related molecules, which are primarily involved in regulating various physiological processes in plants, such as responses to stress, defense against herbivores, and growth and development.
The primary mechanism of action for Jaz inhibitors typically involves their interaction with JAZ proteins or associated molecules, leading to the disruption of their normal functions. By inhibiting JAZ proteins, these compounds may potentially influence the signaling pathways that govern plant responses to environmental stimuli. Researchers studying Jaz inhibitors aim to elucidate the specific roles and functions of JAZ proteins and related components in plant biology, contributing to our understanding of their significance in plant growth, development, and adaptation to changing conditions. These inhibitors serve as valuable tools for advancing our knowledge of plant molecular biology and signaling pathways, facilitating research into how plants respond to various environmental cues. In this context, they contribute to expanding our understanding of the complex world of plant physiology and adaptation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone intercalates into DNA and inhibits topoisomerase II, potentially disrupting ZNF346-mediated transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to DNA and inhibits transcriptional elongation, which could reduce the expression of genes regulated by ZNF346. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits topoisomerase I, leading to DNA damage and potentially affecting the activity of DNA-binding proteins like ZNF346. | ||||||
Quinomycin A | 512-64-1 | sc-202306 | 1 mg | $166.00 | 4 | |
A DNA-binding compound that could impede the binding of ZNF346 to its target DNA sequences. | ||||||
Chromomycin A3 | 7059-24-7 | sc-200907 | 10 mg | $260.00 | ||
Chromomycin A3 binds to GC-rich regions of DNA, potentially disrupting ZNF346-DNA interactions. | ||||||
Aminopterin | 54-62-6 | sc-202461 | 50 mg | $102.00 | 1 | |
Aminopterin inhibits dihydrofolate reductase, leading to reduced DNA synthesis, and could consequently affect ZNF346 levels. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Aphidicolin selectively inhibits DNA polymerase, which could indirectly decrease ZNF346 expression. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide has been shown to inhibit transcriptional activity broadly and may indirectly affect ZNF346 expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib inhibits the proteasome, leading to increased protein degradation, which could theoretically reduce ZNF346 levels. | ||||||